New Zealand markets closed

ICON Public Limited Company (ICLR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
318.78+2.78 (+0.88%)
At close: 04:00PM EDT
318.79 +0.01 (+0.00%)
After hours: 04:24PM EDT

ICON Public Limited Company

South County Business Park
Leopardstown
Dublin D18 X5R3
Ireland
353 1 291 2000
https://www.iconplc.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees41,150

Key executives

NameTitlePayExercisedYear born
Dr. Steven A. Cutler MBA, Ph.D.CEO & Director2.59MN/A1960
Dr. John Climax Ph.D.Founder & Independent Non-Executive Director90kN/A1953
Mr. Brendan BrennanChief Financial Officer1.07MN/A1979
Jonathan Andrew CurtainSenior Vice President of Corporate & Commercial FinanceN/AN/A1976
Mr. Thomas N. O'LearyChief Information OfficerN/AN/AN/A
Mr. Diarmaid CunninghamChief Administrative Officer, General Counsel & Company SecretaryN/AN/A1975
Ms. Niamh MurphyDirector of Corporate CommunicationsN/AN/AN/A
Mr. David GreenVice President of MarketingN/AN/AN/A
Mr. Joe CroninChief Human Resources OfficerN/AN/AN/A
Mr. Simon HolmesPresident of Corporate Investments & PartnershipsN/AN/A1967
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Corporate governance

ICON Public Limited Company’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.